rs72677250
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_001267550.2(TTN):āc.50812G>Cā(p.Glu16938Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,612,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E16938K) has been classified as Uncertain significance.
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TTN | NM_001267550.2 | c.50812G>C | p.Glu16938Gln | missense_variant | Exon 269 of 363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TTN | ENST00000589042.5 | c.50812G>C | p.Glu16938Gln | missense_variant | Exon 269 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151972Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000202 AC: 5AN: 247626 AF XY: 0.0000149 show subpopulations
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1460772Hom.: 0 Cov.: 33 AF XY: 0.0000151 AC XY: 11AN XY: 726694 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151972Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74192 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:2
Variant summary: TTN c.43108G>C (p.Glu14370Gln) results in a conservative amino acid change located in the A band domain of the encoded protein sequence. Two of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 247626 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.43108G>C has been reported in the literature in individuals affected with Dilated Cardiomyopathy (Begay_2015). This report does not provide unequivocal conclusions about association of the variant with Dilated Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. -
The Glu14370Gln variant in TTN has been identified in 1 Caucasian individual wit h DCM, who also carried a TTN frameshift variant (LMM unpublished data), but has not been identified in large population studies. It has been identified in 1/34 4 chromosomes from a clinical cohort though no details are available (Mestroni; dbSNP rs72677250). Computational analyses (biochemical amino acid properties, co nservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impact to the protein. At this time, additional information is neede d to fully assess the clinical significance of this variant. -
Cardiovascular phenotype Uncertain:1
The p.E7873Q variant (also known as c.23617G>C), located in coding exon 96 of the TTN gene, results from a G to C substitution at nucleotide position 23617. The glutamic acid at codon 7873 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at